Evidence map›Paper›PMID 34190433›Full record

ReviewInvestigative and clinical urology2021

Asian Conference on Tumor Ablation guidelines for renal cell carcinoma.

Byung Kwan Park, Shu Huei Shen, Masashi Fujimori, Yi Wang

Abstract readReview
In one paragraph

Review in Investigative and clinical urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Percutaneous Thermal Ablation for Managing Small Renal Metastatic Tumors.Interventional radiology (Higashimatsuyama-shi (Japan) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Byung Kwan ParkDepartment of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 1436park@gmail.com.ORCID 0000-0002-4114-8859
Shu Huei ShenDepartment of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0002-2776-4671
Masashi FujimoriDepartment of Radiology, Mie University School of Medicine, Mie Prefecture, Japan.ORCID 0000-0002-8244-3176
Yi WangDepartment of Urology, Peking University Wujieping Urology Center, Peking University Shougang Hospital, Beijing, China.ORCID 0000-0002-3089-9403

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thermal ablation has been established as an alternative treatment for renal cell carcinoma (RCC) in patients who are poor candidates for surgery. However, while American and European guidelines have been established for American and European patients, respectively, no ablation guidelines for Asian patients with RCCs have been established many years after the Asian Conference on Tumor Ablation (ACTA) had been held. Given that Western guidelines are difficult to apply to Asian patients due to differences in body habitus, economic status, and insurance systems, the current review sought to establish the first version of the ACTA guidelines for treating a RCC with thermal ablation.

Indexed as

Practice Guidelines as TopicAblation TechniquesCarcinoma, Renal CellCongresses as TopicCryosurgeryHumansKidney NeoplasmsMicrowavesPatient SelectionPreoperative CareRadiofrequency AblationCarcinoma, renal cellCryosurgeryMicrowavesRadiofrequency ablation

Identifiers

PMID34190433
PMCPMC8246015

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.